{
    "2018-07-31": [
        [
            {
                "time": "",
                "original_text": "贝达药业：3项目进入Ⅲ期临床研究 肺癌抑制剂年底提交上市申请",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "肺癌抑制剂",
                        "Ⅲ期临床研究",
                        "上市申请"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "广东大范围下调抗癌药价格 上市药企迎“以价换量”机会",
                "features": {
                    "keywords": [
                        "广东",
                        "抗癌药价格",
                        "以价换量",
                        "上市药企"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}